Related references
Note: Only part of the references are listed.Risk Factors for Adverse Symptoms During Dipeptidyl Peptidase-IV Inhibitor Therapy: A Questionnaire-Based Study Carried Out by the Japan Pharmaceutical Association Drug Event Monitoring Project in Kumamoto Prefecture
Ayami Kajiwara et al.
DRUG SAFETY (2013)
High normal blood pressure is an independent risk factor for cardiovascular disease among middle-aged but not in elderly populations: 9-year results of a population-based study
F. Hadaegh et al.
JOURNAL OF HUMAN HYPERTENSION (2013)
Health-related quality of life is worse in individuals with hypertension under drug treatment: results of population-based study
D. J. Trevisol et al.
JOURNAL OF HUMAN HYPERTENSION (2012)
Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study (Publication with Expression of Concern. See vol. 19, 2018)
Roberto Fogari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients (Publication with Expression of Concern. See vol. 19, 2018)
Roberto Fogari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients
R. E. Schmieder et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
Premenopausal Women Have Increased Risk of Hypertensive Target Organ Damage Compared with Men of Similar Age
Paolo Palatini et al.
JOURNAL OF WOMENS HEALTH (2011)
Effect of Valsartan or Olmesartan Addition to Amlodipine on Ankle Edema in Hypertensive Patients
Roberto Fogari et al.
ADVANCES IN THERAPY (2010)
Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with Hypertension Focus on Amlodipine/Valsartan
Pedro Marques da Silva
CLINICAL DRUG INVESTIGATION (2010)
Antihypertensive drug therapy and blood pressure control in men and women: an international perspective
M. Thoenes et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Factors Associated With Compliance, Discontinuation and Switching of Calcium Channel Blockers in 20,156 Chinese Patients
Martin C. S. Wong et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy A Randomized, Double-Blind, Parallel-Group, Multicentre Study
Massimo Volpe et al.
CLINICAL DRUG INVESTIGATION (2009)
Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor
Inmaculada C. Villar et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Short-term safety and tolerability of antihypertensive agents in Korean patients: An observational study
YS Kim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2000)
Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries
B Fisslthaler et al.
HYPERTENSION (2000)
Share Paper
